Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MTNB

Matinas BioPharma

$1.22

(0.00%)

08:45
03/15/19
03/15
08:45
03/15/19
08:45
Syndicate
Matinas BioPharma 27.3M share Spot Secondary priced at $1.10 »

BTIG acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

MTNB

Matinas BioPharma

$1.22

(0.00%)

17:04
03/14/19
03/14
17:04
03/14/19
17:04
Syndicate
Matinas BioPharma files to sell common stock, no amount given »

BTIG is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$1.30

0.03 (2.36%)

04:55
03/08/19
03/08
04:55
03/08/19
04:55
Conference/Events
Matinas BioPharma management to meet with BTIG »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

MTNB

Matinas BioPharma

$1.27

-0.09 (-6.62%)

15:24
03/06/19
03/06
15:24
03/06/19
15:24
Conference/Events
Matinas BioPharma management to meet with BTIG »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

MTNB

Matinas BioPharma

$1.08

0.06 (5.88%)

, AMGN

Amgen

$187.48

2.21 (1.19%)

08:35
02/25/19
02/25
08:35
02/25/19
08:35
Hot Stocks
Matinas BioPharma appoints James Ferguson as CMO »

Matinas BioPharma (MTNB)…

MTNB

Matinas BioPharma

$1.08

0.06 (5.88%)

AMGN

Amgen

$187.48

2.21 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
MTNB

Matinas BioPharma

$1.04

-0.045 (-4.17%)

08:31
02/11/19
02/11
08:31
02/11/19
08:31
Initiation
Matinas BioPharma initiated at Roth Capital »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
MTNB

Matinas BioPharma

$0.97

-0.17 (-14.91%)

, AMRN

Amarin

$19.83

-1.2 (-5.71%)

07:47
11/13/18
11/13
07:47
11/13/18
07:47
Recommendations
Matinas BioPharma, Amarin analyst commentary at Maxim »

Matinas BioPharma price…

MTNB

Matinas BioPharma

$0.97

-0.17 (-14.91%)

AMRN

Amarin

$19.83

-1.2 (-5.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$1.01

0.1287 (14.69%)

16:38
11/08/18
11/08
16:38
11/08/18
16:38
Hot Stocks
Breaking Hot Stocks news story on Matinas BioPharma »

Boxer Capital reports 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.79

-0.0462 (-5.53%)

08:59
10/18/18
10/18
08:59
10/18/18
08:59
Hot Stocks
Matinas BioPharma announces issuance of U.S. patent for MAT9001 »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTNB

Matinas BioPharma

$0.82

0.0363 (4.63%)

08:38
10/15/18
10/15
08:38
10/15/18
08:38
Hot Stocks
Matinas BioPharma appoints Theresa Matkovits as CDO »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.